Loading...
OTC Markets
Totals
Securities
12,299
Dollar Vol
$2.6B
Share Vol
5.4B
Trades
376,657

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

PSYCF
Psyched Wellness Ltd.

Ordinary Shares

0.0165

-0.00155

-8.59%

0.0137 / 0.02 (45000 x 48000)

Real-Time Best Bid & Ask: 05:00pm 07/17/2025
Delayed (15 Min) Trade Data: 12:00am 07/17/2025
Psyched Wellness Ltd. Company Logo

36 Toronto Street

Suite 701

Toronto, ON M5C 2C5

Canada

Principal Executive Offices:

36 Toronto Street

Suite 701

Toronto, ONT M5C 2C5

Canada

Business Description
Psyched Wellness Ltd. is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods. The Company's objective is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category. The Company is in the process of developing a line of Amanita muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives: promote stress relief, relaxation and assist with restful sleeping.
Financial Reporting
Reporting Status
International Reporting: Canadian Securities Exchange
Audited Financials
Audited
CIK
0001847706
Fiscal Year End
11/30
Company Officers & Contacts
Jeffrey James Stevens
CEO

David Shisel
COO

Kyle Nazareth
CFO

Board of Directors
Michael Nederhoff
Chairman, Independent Director, Audit Committee Member

Nickolas Kadysh
Independent Director

Trevor Mayer
Independent Director

David Nutt
Independent Director

Prof. Nutt is a psychiatrist and the Edmund J. Safra Professor of Neuropsychopharmacology in the Division of Brain Science, Dept of Medicine, Imperial College London where he uses a range of brain imaging techniques to explore the causes of addiction and other psychiatric disorders and to search for new treatments. Prof. Nutt has published over 400 original research papers, a similar number of reviews and books chapters, eight government reports on drugs and 28 books, including one for the general public entitled "Drugs: Without The Hot Air", that won the Transmission Prize in 2014. Prof. Nutt is currently the President of the European Brain Council and Founding Chair of Drug Science. Previously he held the position of President of the British Association of Psychopharmacology, the British Neuroscience Association, and the European College of Neuropsychopharmacology. He broadcasts widely to the general public both on radio and television. In 2010, The Times Eureka science magazine voted him one of the 100 most important figures in British Science, and the only psychiatrist on the list. In 2013, Mr. Nutt was awarded the John Maddox Prize from Nature/Sense about Science for standing up for science.

Lauren Spikes
Audit Committee Member

Jeffrey James Stevens
Nominating Committee Member

Janeen Stodulski
Independent Director, Audit Committee Member

Other Company Insiders

None

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
Clearhouse LLP

Suite 527 - 2560 Matheson BLVD E,

Mississauga, ON L4Y 4Y9

Canada

Securities Counsel
DLA Piper

250 2 St SW #1000

Calgary, AB T2P 0C1

Canada

Profile Data
SIC - Industry Classification
5499 - Miscellaneous food stores
Incorporation Information
ON, CA, 1981
Employees
2 as of 08/06/2024
Shell
No
Products and Services

The Company is in the process of developing a line of Amanita muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives: promote stress relief, relaxation and assist with restful sleeping.

Company Facilities

The company does not own or lease any property. All of its operations (including pre-clinical trials and product development) accrue in facilities that are owned or leased by the companies that are providing services to the company.

Company Notes
Formerly=Duncan Park Holdings Corporation until 10-2020
OTCQB Venture Market Logo
Joined OTCQB 12/2020
The Company Profile data was verified by the issuer within the previous 6 months.
This security is not a Penny Stock as defined in SEC Rule 240.3a51-1.
This company has certified to OTC Markets Group that it is eligible to rely on the exemption from registration under Securities and Exchange Act Rule 12g3-2(b).
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.